Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 19 record(s)

Req # A-2023-025599

For FY 2015-2022 (inclusive), how many investigations into prescription pricing on the basis that the pricing exceeded the guidelines resulted in a public hearing? Of those that resulted in a public hearing, in how many was the pricing found to be excessive? Of those that were found to be excessive, how many resulted in orders to reduce the prescription price?

Organization: Patented Medicine Prices Review Board Canada

1 page(s)
July 2023

Req # A-2023-025896

For fiscal years 2015-2022 (inclusive), how many new patented medicines were reported to the board by Bayer, Inc.? From among those reports, how many included claims that a price exceeded the guidelines?

Organization: Patented Medicine Prices Review Board Canada

588 page(s)
July 2023

Req # A-2023-11914

Number of instances in which the ATIP unit used section 20(6) (the public interest override) of the Access to Information Act, as tallied by the documentation retained in accordance with the Manual. No time limit; assess based on period of available documentation (and please indicate this period).

Organization: Patented Medicine Prices Review Board Canada

1 page(s)
April 2023

Req # A-2022-09059

Copies of all submissions or comments received in response to the PMPRB's 2022 Guidelines consultation, including any late consultation submissions received on December 6th or 7th. So this request runs from October 6th to December 7th, 2022. If Health Canada or any other federal government department provided comments outside of the consultation process I would like a copy of those comments as well.

Organization: Patented Medicine Prices Review Board Canada

0 page(s)
December 2022

Req # A-2021-24949

Copies of all records related to the board meeting regarding the consultation results update on September 1, 2021 as referenced in Douglas Clark's calendar.

Organization: Patented Medicine Prices Review Board Canada

1 page(s)
January 2022

Req # A-2021-24950

Copies of all communication plans, strategies or similar documents prepared by PMPRB staff between May 1, 2021 and December 20, 2021.

Organization: Patented Medicine Prices Review Board Canada

7 page(s)
January 2022

Req # A-2021-00001

Copies of all meeting minutes, presentations and speaking notes associated with the following 2018 meetings of the PMPRB Steering Committee on Modernization of Price Review Process Guidelines and the working group struck to inform that committee: July 26, August 15, August 22, August 24, September 12, September 25, October 12 and December 13.

Organization: Patented Medicine Prices Review Board Canada

154 page(s)
December 2021

Req # A-2021-10643

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Biosimilars Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

21 page(s)
December 2021

Req # A-2021-10676

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and PDCI Market Access over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

5 page(s)
December 2021

Req # A-2021-10684

Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and GlaxoSmithKline Inc. over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 9, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.

Organization: Patented Medicine Prices Review Board Canada

4 page(s)
December 2021
Date modified: